Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
03/23 RITE AID : MMR Vaccine Available Upon Request at Rite Aid Pharmacies in 28 State..
03/23 RITE AID : Albany police make arrest in connection with Rite Aid burglaries
03/21 RITE AID : Winning Lottery tickets sold in Uniontown and Monongahela
03/21 RITE AID : Winning Cash 5 lottery ticket sold in Monongahela
03/20 RITE AID : Kicks Off 23rd Annual Miracle Balloon Campaign to Support Children&rs..
03/20 Fred's pharmacy schedules fourth quarter and full-year 2016 earnings; announc..
03/20 RITE AID : Kicks Off 23rd Annual Miracle Balloon Campaign to Support Children's ..
03/17 RITE AID : Police Beat March 17
03/17 RITE AID : Virginia Beach couple wins lottery twice in 3 months, totaling $1.25 ..
03/15 RITE AID : MMR Vaccine Available Upon Request at Rite Aid Pharmacies in 28 State..
More news
Sector news : Retail - Drugs without Grocery
03/08DJHealth Costs Get a Rethink -- WSJ
02/28 Valeant predicts tough 2017 with revenue to decline
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
03/23 RITE AID : A 'Win' No Matter What?
03/23 Retail stocks churn higher
03/22 AMERISOURCEBERGEN : Fear Of Regulatory Changes Presents An Attractive Upside Pot..
03/21 Rite Aid shares could be cut in half if Walgreens deal fails, analyst says
03/14 Walgreens working to sell more stores to Fred's - Bloomberg
Advertisement
Financials ($)
Sales 2017 32 589 M
EBIT 2017 470 M
Net income 2017 27,0 M
Debt 2017 6 964 M
Yield 2017 -
P/E ratio 2017 226,50
P/E ratio 2018
EV / Sales 2017 0,36x
EV / Sales 2018 0,35x
Capitalization 4 767 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 6,54 $
Spread / Average Target 44%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & CEO-Rite Aid Stores
Bryan B. Everett Executive Vice President-Store Operations
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-45.02%4 767
RAIA DROGASIL SA-6.03%6 302
AIN HOLDINGS INC1.42%2 258
ADCOCK INGRAM HOLDINGS..31.22%835
ORIOLA KD OYJ-8.58%784
AUSTRALIAN PHARMACEUTI..0.00%779
More Results